Maxzide and Rezulin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Maxzide (hydrochlorothiazide; triamterene) and Rezulin (troglitazone). Common drug interactions include blood glucose increased among females and back pain among males.

The phase IV clinical study analyzes what interactions people have when they take Maxzide and Rezulin. It is created by eHealthMe based on reports of 66 people who take the same drugs from the FDA, and is updated regularly.

What is Maxzide?

Maxzide has active ingredients of hydrochlorothiazide; triamterene. It is often used in high blood pressure. eHealthMe is studying from 9,152 Maxzide users. Check the latest studies of Maxzide.

What is Rezulin?

Rezulin has active ingredients of troglitazone. eHealthMe is studying from 8,764 Rezulin users. Check the latest studies of Rezulin.



On Jul, 12, 2026

66 people who take Maxzide and Rezulin together, and have interactions are studied.

Maxzide and Rezulin drug interactions.

What are the common drug interactions of Maxzide and Rezulin, by gender? *:

female:

  1. Blood glucose increased
  2. Budd chiari syndrome (problem that results from blood clotting in the veins flowing out of the liver (hepatic veins))
  3. Chest pain
  4. Cholecystitis (infection of gallbladder)
  5. Depression
  6. Gastritis (inflammation of stomach)
  7. Gastro-oesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  8. Glycosylated haemoglobin increased
  9. Haematuria present (presence of blood in urine due to trauma)
  10. Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)

male:

  1. Back pain
  2. Nausea (feeling of having an urge to vomit)
  3. Hepatic necrosis (large portions of liver die off due to severe liver disease)
  4. Hypersensitivity
  5. Insomnia (sleeplessness)
  6. Irritability
  7. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  8. Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
  9. Malaise (a feeling of general discomfort or uneasiness)
  10. Metastases to liver (cancer spreads to liver)

What are the common drug interactions of Maxzide and Rezulin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
  2. Liver fatty (fat deposition of liver)
  3. Vaginal candidiasis (vaginal fungal infection)
  4. Inflammation
  5. Weight increased
  6. Abdominal pain
  7. Chest pain
  8. Constipation
  9. Depression
  10. Diarrhoea

40-49:

  1. Hepatic necrosis (large portions of liver die off due to severe liver disease)
  2. Hepatic fibrosis (scarring process that represents the liver's response to injury)
  3. Haemoglobin decreased
  4. Malaise (a feeling of general discomfort or uneasiness)
  5. Anaemia (lack of blood)
  6. Ascites (accumulation of fluid in the abdominal cavity)
  7. Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
  8. Hepatitis (inflammation of the liver)
  9. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  10. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)

50-59:

  1. Back pain
  2. Cardiac failure congestive
  3. Completed suicide (act of taking one's own life)
  4. Duodenal ulcer
  5. Face oedema (swelling of face)
  6. Faeces discoloured
  7. Flatulence (flatus expelled through the anus)
  8. Gamma-glutamyltransferase increased
  9. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
  10. Hepatic necrosis (large portions of liver die off due to severe liver disease)

60+:

  1. Hepatic failure (liver failure)
  2. Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
  3. Aspartate aminotransferase increased
  4. Atelectasis (partial or complete collapse of the lung)
  5. Facial palsy (paralysis of face nerve)
  6. Hemiparesis (weakness on one side of the body)
  7. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  8. Renal failure acute (rapid kidney dysfunction)
  9. Rib fracture
  10. Spondylosis (a defect of a vertebra)

* Approximation only. Some reports may have incomplete information.

Do you take Maxzide and Rezulin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Maxzide and Rezulin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Maxzide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Rezulin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Maxzide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Rezulin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on hydrochlorothiazide; triamterene and troglitazone (the active ingredients of Maxzide and Rezulin, respectively), and Maxzide and Rezulin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: